FindTrial
Sign In

Randomized study on therapy of Strongyloides stercoralis invasion: ivermectine VS thiabendazole

Randomized study on therapy of Strongyloides stercoralis invasion: ivermectine VS thiabendazole

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2004-004693-87-IT
Enrollment
Unknown
Registered
2005-01-31
Start date
2004-11-03
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Strongyloidiasis MedDRA version: 6.1 Level: SOC Classification code 10021881

Interventions

Trade Name: P02CF01- Ivermectina Product Name: NA Ivermectina Product Code: NA Pharmaceutical Form: Tablet INN or Proposed INN: Ivermectin Concentration unit: mg milligram(s) Concentration type: equa

Sponsors

OSPEDALE SACRO CUORE-DON CALABRIA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026